[go: up one dir, main page]

IN2013MU00916A - - Google Patents

Download PDF

Info

Publication number
IN2013MU00916A
IN2013MU00916A IN916MU2013A IN2013MU00916A IN 2013MU00916 A IN2013MU00916 A IN 2013MU00916A IN 916MU2013 A IN916MU2013 A IN 916MU2013A IN 2013MU00916 A IN2013MU00916 A IN 2013MU00916A
Authority
IN
India
Prior art keywords
formula
preparation
relates
improved process
sitagliptin phosphate
Prior art date
Application number
Inventor
Shriprakash Dhar Dwivedi
Kumar Kamlesh Singh
Sunil Dnyaneshwar Narode
Dhaval Jashvantbhai Patel
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to IN916MU2013 priority Critical patent/IN2013MU00916A/en
Priority to US14/220,836 priority patent/US9409912B2/en
Publication of IN2013MU00916A publication Critical patent/IN2013MU00916A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The present invention relates to an improved process for the preparation of sitagliptin phosphate. More particularly, the invention relates to an improved process for preparation of sitagliptin phosphate anhydrous of Formula (I’) or monohydrate of Formula (I).
IN916MU2013 2013-03-20 2013-03-20 IN2013MU00916A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN916MU2013 IN2013MU00916A (en) 2013-03-20 2013-03-20
US14/220,836 US9409912B2 (en) 2013-03-20 2014-03-20 Process for the preparation of sitagliptin phosphate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN916MU2013 IN2013MU00916A (en) 2013-03-20 2013-03-20

Publications (1)

Publication Number Publication Date
IN2013MU00916A true IN2013MU00916A (en) 2015-06-26

Family

ID=52691500

Family Applications (1)

Application Number Title Priority Date Filing Date
IN916MU2013 IN2013MU00916A (en) 2013-03-20 2013-03-20

Country Status (2)

Country Link
US (1) US9409912B2 (en)
IN (1) IN2013MU00916A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105175422B (en) * 2015-09-18 2018-04-20 深圳市海滨制药有限公司 A kind of phosphoric acid Xi Gelieting crystal and its preparation method and application
CN106124667B (en) * 2016-08-29 2018-07-31 上海应用技术学院 A kind of methods of the separation determination Xi Gelieting in relation to substance
CN109651373A (en) * 2017-10-11 2019-04-19 江苏瑞科医药科技有限公司 A kind of preparation method of Xi Gelieting phosphate monohydrate crystal form
CN114262331A (en) * 2020-09-16 2022-04-01 江苏万邦生化医药集团有限责任公司 Preparation method of sitagliptin phosphate monohydrate

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA74912C2 (en) 2001-07-06 2006-02-15 Merck & Co Inc Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
JO2625B1 (en) 2003-06-24 2011-11-01 ميرك شارب اند دوم كوربوريشن Phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor
TW200602293A (en) 2004-04-05 2006-01-16 Merck & Co Inc Process for the preparation of enantiomerically enriched beta amino acid derivatives
WO2009045507A2 (en) 2007-10-03 2009-04-09 Teva Pharmaceutical Industries Ltd. Processes for preparing an intermediate of sitagliptin via enzymatic reduction
US8334385B2 (en) * 2007-11-02 2012-12-18 Glenmark Generics Limited Process for the preparation of R-sitagliptin and its pharmaceutically acceptable salts thereof
US20090192326A1 (en) 2007-11-13 2009-07-30 Nurit Perlman Preparation of sitagliptin intermediate
JP2011507890A (en) * 2007-12-20 2011-03-10 ドクター・レディーズ・ラボラトリーズ・リミテッド Process for the preparation of sitagliptin and its pharmaceutically acceptable salts
WO2010012781A2 (en) * 2008-07-29 2010-02-04 Medichem, S.A. New crystalline salt forms of a 5,6,7,8-tetrahydro-1,2,4- triazolo[4,3-a]pyrazine derivative
WO2010122578A2 (en) 2009-04-20 2010-10-28 Msn Laboratories Limited Process for the preparation of sitagliptin and its intermediates
CA2759077C (en) * 2009-05-11 2016-02-16 Generics [Uk] Limited Sitagliptin synthesis
KR101222679B1 (en) * 2009-10-21 2013-01-16 한미사이언스 주식회사 Method of preparing sitagliptin and intermediates used therein
ITMI20110765A1 (en) 2011-05-05 2012-11-06 Chemo Iberica Sa PROCESS FOR SITAGLIPTINA PRODUCTION
WO2013013833A1 (en) 2011-07-27 2013-01-31 Farma Grs, D.O.O. Process for the preparation of sitagliptin and its pharmaceutically acceptable salts

Also Published As

Publication number Publication date
US20150087834A1 (en) 2015-03-26
US9409912B2 (en) 2016-08-09

Similar Documents

Publication Publication Date Title
PH12016500676A1 (en) Pyrimidine fgfr4 inhibitors
PH12016501192A1 (en) Tetrahydropyridopyrazines modulators of gpr6
MA39987A (en) Processes of preparing a jak1 inhibitor and new forms thereto
PH12015502248B1 (en) 6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide derivatives and their use as phd inhibitors
NZ711192A (en) Process for making benzoxazepin compounds
NI201200195A (en) PROCEDURE FOR THE PREPARATION OF THE PERINDOPRYL L-ARGININE SALT
NZ720106A (en) A process for the preparation of regadenoson
IN2013MU00916A (en)
IN2013MU01113A (en)
IN2015DN02444A (en)
MY174153A (en) Processes for the preparation of pyrimidinylcyclopentane compounds
WO2014177978A3 (en) An improved process for the preparation of teriflunomide
IN2014DN10209A (en)
IN2013MU04056A (en)
IN2013MU01219A (en)
IN2013MU03768A (en)
MX361673B (en) Process for the preparation of boronic acid intermediates.
IN2013CH05865A (en)
IN2013DE03592A (en)
IN2014MU00069A (en)
IN2013CH04519A (en)
IN2013CH05395A (en)
IN2013MU00647A (en)
IN2013CH05863A (en)
MX2017010192A (en) Process of production of cyclo-dehydrolinalool (i).